Management of Asthma Exacerbation in the Emergency Department
The initial treatment for asthma exacerbation in the ED should consist of oxygen therapy to maintain SaO2 >90%, inhaled short-acting β2-agonists (SABA) administered every 20-30 minutes for the first hour, and systemic corticosteroids, with the addition of ipratropium bromide for severe exacerbations. 1
Initial Assessment and Triage
- Rapidly assess severity based on:
- Respiratory rate and work of breathing
- Oxygen saturation (SaO2)
- Use of accessory muscles
- Ability to speak in complete sentences
- Mental status
- Peak expiratory flow (PEF) or FEV1 if patient can perform
Primary Treatment Algorithm
1. Oxygen Therapy
- Administer oxygen via nasal cannula or mask to maintain SaO2 >90% (>95% in pregnant women and patients with heart disease)
- Monitor oxygen saturation continuously until clear response to bronchodilator therapy 1
- Caution: Titrate oxygen to target saturation rather than giving high-concentration oxygen, as hyperoxemia can increase PaCO2 in severe asthma 2
2. Inhaled Short-Acting β2-agonists (SABA)
- Administer albuterol via nebulizer or metered-dose inhaler (MDI) with spacer:
- For severe exacerbations (FEV1 or PEF <40% predicted):
3. Systemic Corticosteroids
- Administer early to all patients with moderate-to-severe exacerbations and those not responding to initial SABA therapy 1
- Dosage:
- Oral administration is preferred unless patient is unable to take oral medications or has vomiting 1
4. Ipratropium Bromide
- Add to SABA therapy for severe exacerbations 1, 5
- Dosage:
- Can be administered as combination with albuterol for up to 3 hours in initial management 1
- The combination of SABA and ipratropium has been shown to reduce hospitalizations, particularly in patients with severe airflow obstruction 1, 6
5. Magnesium Sulfate (for Severe Exacerbations)
- Consider IV magnesium sulfate for severe exacerbations not responding to conventional therapy after 1 hour 7
- Dosage:
- Adults: 2 g IV over 20 minutes
- Children: 25-50 mg/kg (maximum 2 g) IV over 20 minutes 7
- One-time dose, not to be repeated routinely 7
Delivery Method Considerations
- Both nebulizers and MDIs with spacers are effective delivery methods 1, 8, 6
- MDI with spacer may be superior to nebulizer in children with severe exacerbations 6
- For patients unable to use MDI effectively (due to age, agitation, or severity), nebulizer therapy is preferred 1
Monitoring and Reassessment
- Monitor vital signs, oxygen saturation, and work of breathing
- Reassess response to treatment after each dose of bronchodilator
- Measure PEF or FEV1 if patient is able to perform the maneuver
- Arterial blood gas measurement for patients with:
- Suspected hypoventilation
- Severe distress
- FEV1 or PEF ≤25% of predicted after initial treatment 1
Common Pitfalls to Avoid
- Delaying corticosteroid administration - Early administration reduces hospitalization rates
- Underestimating severity - Patients with severe exacerbations may have deceptively minimal wheezing due to poor air movement
- Overuse of oxygen - Titrate to target saturation rather than giving high-concentration oxygen 2
- Inadequate bronchodilator dosing - Many patients require higher doses than standard 2.5 mg of albuterol 4
- Unnecessary antibiotics - Reserve for cases with clear evidence of bacterial infection 1
- Delaying intubation when needed - For impending respiratory failure, intubate semi-electively before respiratory arrest occurs 1
By following this evidence-based approach to managing asthma exacerbations in the ED, you can optimize outcomes and reduce morbidity and mortality associated with severe asthma attacks.